One sentence summary: Cone specification in human organoids
been studied for their promise of therapeutic applications (15) , our work demonstrates that human organoids can also be used to reveal fundamental mechanisms of human development.
Specification of cone cells in organoids recapitulates development in the human retina
We compared features of cone subtypes in human organoids to adult retinal tissue. Adult human retinas and organoids at day 200 of differentiation displayed similar ratios of S to L/M cones as indicated by expression of S-or L/M-opsins (adult: S=13%, L/M=87%; organoid: S=29%, L/M=71%)( Fig. 1B-C,   S1A ). We examined L/M cones with an antibody that recognizes both L-and Mopsin proteins due to their extremely high similarity. Both S and L/M cones expressed the cone-rod-homeobox transcription factor (CRX), a critical transcription factor for photoreceptor differentiation ( Fig. 2A, E) (16) (17) (18) , indicating proper fate specification in organoids. Additionally, cones in organoids and retinas displayed similar morphologies, with L/M cones that had longer outer segments and wider inner segments than S cones ( Fig. 2B-D, F-H) (19) . The outer segments of cones were shorter in organoids than in adult retinas, consistent with postnatal maturation (Fig. 2D, H) (20) . Thus, cone subtypes in human retinal organoids displayed distributions, gene expression patterns, and morphologies similar to cones of the human retina.
We next examined the developmental dynamics of cone subtype specification in organoids. In the human retina, S cones are generated during fetal weeks 11-34 (days 77-238), whereas LM cones are specified later during fetal weeks 14-37 (days 98-259) (21, 22) . We tracked the ratios and densities of S and L/M cones in organoids by antibody staining over 360 days of differentiation.
A significant number of cones expressing S-opsin were first observed at day 150 ( Fig. 2I, L-M) . The density of S cones leveled off at day 170 ( Fig. 2M) , at the timepoint when cones expressing L/M-opsin began to be observed ( Fig. 2J-M) .
The population of L/M cones increased dramatically until day 300 ( Fig. 2K-M) when they reached a steady-state density. Remarkably, the 20-day difference between S-and L/M-opsin expression onset in retinal organoids is similar to the 20-day difference observed in the appearance of S-and L/M-cones in the fetal retina (21) . These observations show a temporal switch from S cone specification to L/M cone specification during retinal development.
We next conducted RNA-Seq through 250 days of iPSC-derived organoid development. We found that S-opsin RNA was expressed first at day 111 and leveled off at day 160, while L/M-opsin RNA was expressed at day 160 and remained steady after day 180, consistent with the timeline of photoreceptor maturation in organoids and fetal retinas ( Fig. 2N, Fig S1B) . Moreover, CRX RNA and CRX protein were expressed before opsins in organoids, similar to human development (23) ( Fig. 2N, Fig. S1B-G,) . Thus, human organoids recapitulate many aspects of the developmental timeline of cone subtype specification observed in human retinas, providing a model system to uncover the mechanisms of these developmental changes.
Thyroid hormone signaling is necessary and sufficient for the temporal switch between S and L/M fate specification
Seminal work in mice identified thyroid hormone receptor β2 (Thrβ2) as a critical regulator of cone subtype specification: Thrβ2 mutants display a complete loss of M-opsin expression and a complete gain of S-opsin expression in cone photoreceptors (24) (25) (26) . Similar roles for Thrβ2 have been characterized in other organisms with highly divergent cone patterning (27) (28) (29) . Additionally, rare human mutations in Thrβ2 are reported to alter color perception, indicative of a change in the S to L/M cone ratio (30). To directly test the role of Thrβ2 in human cone subtype specification, we used CRISPR/Cas9 in human embryonic stem cells (ESCs) to generate a homozygous mutation resulting in early translational termination in the unique first exon of Thrβ2 (Fig. S2A) . Surprisingly, organoids derived from these mutant stem cells displayed no changes in cone subtype ratio or density (wild-type: S=62%, L/M=38%; Thrβ2 KO: S=59%, L/M=41%; P=0.83), indicating that, unlike previous suggestions based on other species, Thrβ2 is dispensable for cone subtype specification in humans ( Fig. 3A-C) .
Since Thrβ2 alone is not required for human cone subtype specification, we reexamined data from Weiss et. al (30) and found that missense mutations in exons 9 and 10 affected both Thrβ2 and another isoform of the human Thrβ gene, Thrβ1 (Fig. S2A) . Thus, we asked whether Thrβ1 and Thrβ2 together are required for cone subtype specification in humans. To completely ablate Thrβ function (i.e. Thrβ1 and Thrβ2), we used CRISPR/Cas9 in human ESCs to delete a shared exon that codes for part of the DNA-binding domain (DBD) of Thrβ (Fig.  S2A ). Thrβ null mutant retinal organoids displayed a complete conversion of all cones to the S subtype (wild-type: S=27%, L/M=73%; Thrβ KO: S=100%, L/M=0%; P<0.0001) ( Fig. 3D-E, H) . In these mutants, all cones expressed Sopsin and had the S cone morphology ( Fig. 3I-J) . Thus, Thrβ is required to activate L/M and to repress S cone fates in the human retina.
Thrβ binds with high affinity to triiodothyronine (T3), the more active form of thyroid hormone, to regulate gene expression (31). Since L/M cones differentiate after S cones, we hypothesized that T3 acts through Thrβ late in retinal development to induce L/M cone fate and repress S cone fate. One prediction of this hypothesis is that addition of T3 early in development will induce L/M fate and repress S fate. To test this model, we added 20nM T3 to ESC-and iPSC-derived organoids starting from days 20-50 to day 200 of differentiation. We observed a dramatic conversion of cone cells to L/M fate (wild-type: S=27%, L/M=73%; wild-type + T3: S=4%, L/M=96%; P<0.01) ( Fig. 3F,   H, Fig. S2B ). Thus, early addition of T3 is sufficient to induce L/M fate and suppress S fate.
To test whether T3 acts specifically through Thrβ to control cone subtype specification, we differentiated Thrβ mutant organoids with early T3 addition.
Thrβ mutation completely suppressed the effects of T3, generating organoids with only S cones (wild-type + T3: S=4%, L/M=96%; Thrβ KO + T3: S=100%, L/M=0%; P<0.0001) ( Fig. 3F-H) . We conclude that T3 acts though Thrβ to promote L/M cone fate and suppress S cone fate.
We confirmed the regulation of L/M-opsin expression through thyroid hormone signaling in a retinoblastoma cell line, which expresses L/M-opsin when treated with T3 ( Fig. S2C-D) (32). T3-induced activation of L/M-opsin expression was suppressed upon RNAi knock down of Thrβ (Fig. S2E-F) , similar to the suppression observed in human organoids.
Interestingly, in organoids, early T3 addition not only converted cone cells to L/M fate but also dramatically increased cone density (Fig. 3F, K) . Moreover, T3 acts specifically through Thrβ to control cone density (Fig. 3G, K) . Early T3 addition may increase cone density by advancing and extending the temporal window of L/M cone generation.
Together, these results demonstrate that T3 signals though Thrβ to promote L/M cone fate and repress S cone fate in developing human retinal tissue.
Dynamic expression of thyroid hormone-regulating genes during development
Our data suggest that temporal control of thyroid hormone signaling determines the S vs. L/M cone fate decision, whereby low signaling early induces S fate and high signaling late induces L/M fate. Thyroid hormone exists largely in two states: Thyroxine (T4), the most abundant circulating form of thyroid hormone, and T3, which binds thyroid hormone receptors with high affinity (31, 33). Conversion of T4 to T3 occurs locally in target tissues to induce gene expression responses (34, 35) . Deiodinases, enzymes that modulate the levels of T3 and T4, are expressed in the retinas of mice, fish, and chicken (29, (36) (37) (38) (39) (40) .
Therefore, we predicted that T3-and T4-degrading enzymes would be expressed during early human eye development to reduce thyroid hormone signaling and specify S cones, while T3-producing enzymes, carriers, and transporters would be expressed later in human eye development to increase signaling and generate L/M cones.
To test these predictions, we examined gene expression across 250 days of organoid development. The expression patterns of thyroid hormone-regulating genes were grouped into three classes: changing expression ( Fig. 4A) , consistent expression ( Fig. 4B) , or no expression ( Fig. 4C) . Interestingly, Deiodinase 3 (DIO3), an enzyme that degrades T3 and T4 (34), was expressed at high levels early in organoid development but at low levels later (Fig. 4A) .
Conversely, Deiodinase 2 (DIO2), an enzyme that converts T4 to active T3 (34), was expressed at low levels early but then dramatically increased over time (Fig.   4A ). We examined RNA-Seq data from Hoshino et. al (23) and found that developing human retinas display similar temporal changes in expression of DIO3 and DIO2 (Fig. S3A) . Deiodinase 1 (DIO1), which regulates T3 and T4 predominantly in the liver and kidney (41), was not expressed in organoids or retinas (Fig. 4C, S3C) . Thus, the dynamic expression of Dio3 and Dio2 supports low thyroid hormone signaling early in development to generate S cones and high thyroid hormone signaling late to produce L/M cones.
Consistent with a role for high thyroid hormone signaling in the generation of L/M cones later in development, expression of transthyretin (TTR), a thyroid hormone carrier protein, increased during organoid and retinal development (Fig.   4A, S3A) (23) . In contrast, albumin (ALB) and thyroxine-binding globulin (SERPINA7), other carrier proteins of T3 and T4, were not expressed in organoids or retinas (Fig. 4C, S3C)(23) .
T3 and T4 are transported into cells via membrane transport proteins (42) .
The T3/T4 transporters SLC7A5 and SLC7A8 increased in expression during organoid differentiation (Fig. 4A) . Additionally, two T3/T4 transporters, SLC3A2 and SLC16A2, were expressed at high and consistent levels throughout organoid development (Fig. 4B) . Other T3/T4 transporters (SLC16A10, SLCO1C1, SLC5A5) were not expressed in organoids ( Fig. 4C) , suggesting tissue-specific regulation of T3/T4 uptake. We observed similar expression patterns of T3/T4 transporters in human retinas ( Fig. S3A-C) (23) .
We next examined expression of transcriptional activators and repressors that mediate the response to thyroid hormone. Consistent with Thrβ expression in human cones (43) , expression of Thrβ in organoids increased with time as cone cells were specified (Fig. 4A) . Expression of thyroid hormone receptor a (Thra) similarly increased with time ( Fig. 4A) . Thyroid hormone receptor cofactors, co-repressor NCoR2 and co-activator MED1, were expressed at steady levels during organoid differentiation (Fig. 4B) . Similar temporal expression patterns were observed in human retinas ( Fig. S3A-B)(23) . Thus, our data suggest that expression of Thrβ and other transcriptional regulators enables gene regulatory responses to differential thyroid hormone levels.
A complex pathway controls production of thyroid hormone. Thyrotropinreleasing hormone (TRH) is produced by the hypothalamus and other neural tissue. TRH stimulates release of thyroid-stimulating hormone a (CGA) and thyroid-stimulating hormone β (TSHβ) from the pituitary gland. CGA and TSHβ bind the thyroid-stimulating hormone receptor (TSHR) in the thyroid gland. T3 and T4 production requires Thyroglobulin (TG), the substrate for T3/T4 synthesis, and Thyroid Peroxidase (TPO), an enzyme which iodinates tyrosine residues in TG (44) . Interestingly, TRH was expressed in organoids and retinas but the other players were not ( Fig. 4A-C, S3A-C) (23, 45, 46) , suggesting that the retina itself does not generate thyroid hormone, rather it modulates the relative levels of T3 and T4 and expresses TRH to signal for thyroid hormone production in other tissues.
Therefore, the temporal expression of thyroid hormone signaling regulators supports our model that the retina intrinsically controls T3 and T4 levels, ensuring low thyroid hormone signaling early to promote S fate and high thyroid hormone signaling late to specify L/M fate (Fig. 4D) . Our studies identify temporal regulation of thyroid hormone signaling as a mechanism controlling cone subtype specification in humans. Consistent with our findings, preterm human infants with low T3/T4 have an increased incidence of color vision defects (47) (48) (49) (50) . Moreover, our identification of a mechanism that generates one cone subtype while suppressing the other is critical for developing organoid-based therapies to treat diseases such as color blindness, retinitis pigmentosa, and macular degeneration. (2B, D, F, H) . 
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